Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
39 results
D1.01 - Anaphylaxis After Crayfish Consumption with Strong Anisakis simplex Sensitization
D1.13 - A rare case of isolated histaminergic angioedema
D1.15 - True Mugwort Sensitization Presenting as Severe Atopic Dermatitis: A Diagnostic Challenge
D1.02 - Sensitization to Sesame Proteins Despite Negative Conventional Testing
D1.03 - Identification of a Thaumatin-Like Protein as a Shared Allergen in Kiwi and Persimmon: Molecular Analysis in a Case of Anaphylaxis
D1.05 - IgE-Mediated Rice Allergy: The Role of Immunoblotting in Allergen Identification
D1.07 - Risk Stratification Tools in Suspected Beta-Lactam Allergy: A RealLife Delabeling Study
D1.08 - Clinical relevance of troponin C (Cra c 6) sensitization in crustacean allergy
D1.09 - Mast cell disorders in children with food-induced anaphylaxis
D1.10 - Underrecognition of Anaphylaxis in Children: Gaps in Diagnosis and Management
D1.11 - Determinants of allergen sensitization and wheal size variability in skin prick testing in a large outpatient cohort
D1.12 - Cross-Reactivity Between Peach Juice and Cupressaceae Pollen
D1.14 - Biphasic, Refractory, and Persistent Anaphylaxis in Children
D1.06 - When an alergic reaction turns into a cardiac event: clinical characterization of Kounis Syndrome
D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies
D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection
D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper
D2.450 - EUFOREA/EPOS Criteria Applied to a Diverse CRSwNP Cohort: Post Hoc Findings from Twice-Yearly depemokimab ANCHOR-1/-2 trials
D2.451 - Real-life upper and lower airway outcomes of long-term dupilumab treatment in patients with severe chronic rhinosinusitis with nasal polyps
D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download